ESC 365 - DapaTAVI: dapagliflozin in patients undergoing transcatheter aortic valve implantation

ESC Professional Premium Access

DapaTAVI: dapagliflozin in patients undergoing transcatheter aortic valve implantation

Session: A year in review: key trials in coronary and structural interventions shaping guidelines and patient care

Topic: Intervention

Speaker: Professor B. Ibanez (Madrid, ES)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Borja Ibanez

National Centre for Cardiovascular Research CNIC AND Fundacion Jimenez Diaz Hospital, Madrid (Spain)

27 presentations

11 followers

4 more presentations in this session

FLAVOUR II: angiography-derived fractional flow reserve vs. intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease

Speaker: Professor B. Koo (Seoul, KR)

ECLIPSE: orbital atherectomy vs. balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies

Speaker: Doctor P. Genereux (Morristown, US)

COMPARE-TAVI 1: SAPIEN 3 vs. Myval transcatheter heart valves for transcatheter aortic valve implantation

Speaker: Doctor A. Eftekhari (Aalborg, DK)

A year in review: key trials in coronary and structural interventions shaping guidelines and patient care - discussion

Access the full session

A year in review: key trials in coronary and structural interventions shaping guidelines and patient care

Speakers: Professor B. Ibanez, Professor B. Koo, Doctor P. Genereux, Doctor A. Eftekhari

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources

novartis

Explore sponsored resources